Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive
Will any BAC C-suite executive file a Form 4 reporting discretionary open-market sales in Q2 2026 NOT tied to a vest or 10b5-1 plan?
Current Prediction
Why This Question Matters
The March 2026 insider selling cluster had a clean vest-linked explanation. A repeat in Q2 without a vesting trigger would shift the Insider Investigator signal from MIXED to MISALIGNED. This is the bright-line test for governance alignment. The lens explicitly flagged this as the critical follow-up.
Prediction Distribution
Individual Predictions(9 runs)
The March cluster has a clean vest explanation. Q2 has no structural trigger. Historically Q2 sees 0-1 discretionary C-suite sales at BAC. The 10b5-1 exclusion eliminates most scheduled activity. Probability in the 15-25% range.
If Q1 earnings are strong and stock rallies above $52, some insiders may take additional opportunistic sales. The March cluster at $50 range suggests an insider-comfortable level. Slightly higher than historical base.
Discretionary C-suite sales outside of vests are notable events at BAC and rare historically. The Insider Investigator lens flagged this specifically as a monitoring event. Base probability modestly above historical rate given recent pattern.
Base rate for discretionary Q2 C-suite sales at BAC is ~1-2 per quarter across 10 NEOs. The 10b5-1 exclusion removes most, leaving probability ~20-25%.
CEO non-participation in March is the key anchor. Operating management is not signaling conviction-driven selling. Q2 likely quiet.
The March cluster pattern could extend to any executive that held back in March. Co-Presidents and senior VPs might trickle out discretionary sales. Probability slightly above base.
Low base rate. No trigger.
Slight elevation due to recent cluster pattern.
Historical rarity + recent cluster = modest upward adjustment.
Resolution Criteria
Resolves YES if any named executive officer of BAC (as listed in the DEF 14A proxy statement) files a Form 4 showing an open-market sale or dispositive transaction during April 1 - June 30, 2026 that is NOT tied to a vest/grant settlement AND is NOT executed under a pre-existing 10b5-1 plan. The determination excludes: tax withholding dispositions, option exercises, sale-to-issuer transactions, and transactions footnoted as 10b5-1 plan executions. Resolves NO if no qualifying discretionary open-market sale occurs.
Resolution Source
SEC EDGAR Form 4 filings for BAC
Source Trigger
C-suite Form 4 activity in Q2 2026 without vest trigger
Full multi-lens equity analysis